Genomind 360
Learning Center

Healthcare providers

CPIC: New Findings and Current Guidelines

Grand Rounds event card CPIC: New Findings and Current Guidelines

Genomind and guest speaker, Kelly E. Caudle, PharmD, PhD, BCPS, discuss CPIC guidelines. The Clinical Pharmacogenetics Implementation Consortium (CPIC®) is an international consortium interested in facilitating the use of pharmacogenetic tests for patient care. Dr. Caudle presents on CPIC’s newest findings and current guidelines.

Disclaimer: Any reference obtained from this webinar does not constitute or imply an endorsement by CPIC or Dr. Kelly E. Caudle of Genomind and Genomind’s products and services.

Filmed February 24th, 2021

Are You Ready to Upgrade Your Practice with Genomind?

Genomind’s pharmacogenetic testing is the most advanced and comprehensive mental health pharmacogenetic test available. Get access to 24 genes related to mental health, 130+ medications, 10+ conditions, state-of-the-art tools, and 360 degrees of support today!

Continued education to evolve your practice.

Free educational content and resources direct from the Genomind team.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.